Tilt Investment Management Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.91M Sell
3,271
-861
-21% -$503K 2.06% 8
2023
Q3
$2.22M Hold
4,132
1.58% 8
2023
Q2
$1.94M Hold
4,132
1.28% 13
2023
Q1
$1.38M Buy
4,132
+534
+15% +$180K 1.02% 23
2022
Q4
$1.32M Buy
+3,598
New +$1.28M 1.12% 23

Other funds holding LLY

Tilt Investment Management Holdings's LLY Position: Q4 2023 in Review

Tilt Investment Management Holdings reduced its Eli Lilly (LLY) stake by 21% in Q4 2023, selling an estimated $503K and leaving 3,271 shares worth $1.91M. The position accounts for 2.06% of the portfolio, ranked #8.

Tilt Investment Management Holdings first reported a position in LLY in Q4 2022 and has held it in 5 quarters since. The position peaked at $2.22M in Q3 2023. 3,273 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Tilt Investment Management Holdings held 3,271 shares of Eli Lilly worth $1.91M as of Q4 2023.
  • Tilt Investment Management Holdings sold 861 Eli Lilly shares in Q4 2023, an estimated $503K.
  • Eli Lilly made up 2.06% of Tilt Investment Management Holdings's portfolio in Q4 2023, its #8 holding.
  • Tilt Investment Management Holdings first reported a position in Eli Lilly in Q4 2022 and has held it in 5 quarters since.
  • Tilt Investment Management Holdings's Eli Lilly position peaked at $2.22M in Q3 2023.
  • 3,273 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q4 2023, filed 31 Jan 2024.